Review Article
Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature
Table 9
Cervical screening test results for clinician-collected sample according to the Australian guidelines.
| Risk of significant cervical abnormalities | HPV test result | Reflex liquid-based cytology result | Recommended management |
| Low-risk result | HPV not detected | — | Return to screening in 5 years |
| Intermediate-risk result | HPV not 16/18 detected | Negative, possible LSIL or LSIL | Repeat HPV test in 12 months |
| Higher-risk result | HPV not 16/18 detected | Possible HSIL or HSIL | Refer to specialist (colposcopy) | HPV 16/18 detected | Any LBC result | Refer to specialist (colposcopy) |
| — | Unsatisfactory HPV test | — | Collect new sample for the HPV test in 6–12 weeks |
| — | HPV not 16/18 detected | Unsatisfactory | Collect new sample for LBC only in 6–12 weeks |
|
|